möglich sobald bei der ZB eingereicht worden ist.
Systemic Jak1 activation provokes hepatic inflammation and imbalanced FGF23 production and cleavage.
FASEB J. 35:e21302 (2021)
Fibroblast growth factor 23 (FGF23) is a main regulator of mineral homeostasis. Low and high circulating FGF23 levels are associated with bone, renal, cardiovascular diseases, and increased mortality. Understanding the factors and signaling pathways affecting FGF23 levels is crucial for the management of these diseases and their complications. Here, we show that activation of the Jak1/Stat3 signaling pathway leads to inflammation in liver and to an increase in hepatic FGF23 synthesis, a key hormone in mineral metabolism. This increased synthesis leads to massive C-terminal FGF23 circulating levels, the inactive C-terminal fragment, and increased intact FGF23 levels, the active form, resulting in imbalanced production and cleavage. Liver inflammation does not lead to activation of the calcineurin-NFAT pathway, and no signs of systemic inflammation could be observed. Despite the increase of active intact FGF23, excessive C-terminal FGF23 levels block the phosphaturic activity of FGF23. Therefore, kidney function and renal αKlotho expression are normal and no activation of the MAPK pathway was detected. In addition, activation of the Jak1/Stat3 signaling pathway leads to high calcitriol levels and low parathyroid hormone production. Thus, JAK1 is a central regulator of mineral homeostasis. Moreover, this study also shows that in order to assess the impact of high FGF23 levels on disease and kidney function, the source and the balance in FGF23 production and cleavage are critical.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Times Cited
Scopus
Cited By
Cited By
Altmetric
5.191
0.000
4
5
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Schlagwörter
Fgf23 ; Jak/stat Signaling ; Pth ; Calcitriol ; Inflammation; Growth-factor 23; Elevated Fgf23; Expression; Phosphate; Kidney; Transport; Hypophosphatemia; Mechanisms; Resistance; Mutations
Sprache
englisch
Veröffentlichungsjahr
2021
HGF-Berichtsjahr
2021
ISSN (print) / ISBN
0892-6638
e-ISSN
1530-6860
Zeitschrift
FASEB Journal
Quellenangaben
Band: 35,
Heft: 2,
Artikelnummer: e21302
Verlag
Wiley
Verlagsort
Bethesda, Md.
Begutachtungsstatus
Peer reviewed
Institut(e)
CF Comparative Medicine (AVM)
Institute of Epidemiology (EPI)
Institute of Experimental Genetics (IEG)
Institute of Human Genetics (IHG)
Institute of Epidemiology (EPI)
Institute of Experimental Genetics (IEG)
Institute of Human Genetics (IHG)
POF Topic(s)
30202 - Environmental Health
30201 - Metabolic Health
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
30201 - Metabolic Health
30501 - Systemic Analysis of Genetic and Environmental Factors that Impact Health
Forschungsfeld(er)
Genetics and Epidemiology
PSP-Element(e)
G-500900-001
G-504091-004
G-500600-001
G-500600-003
G-500700-001
G-504091-004
G-500600-001
G-500600-003
G-500700-001
Förderungen
University of Zurich
Core
Core
WOS ID
WOS:000647789600092
Scopus ID
85100326428
PubMed ID
33475190
Erfassungsdatum
2021-03-24